ALRTF on OTC
ALR Technologies SG Ltd.
ALR Technologies SG Ltd. is a surgical and medical instruments and apparatus company, listed on OTC (ALRTF).1
$0.01 up 0.00 (0.00%)Price as of Oct 15, 2026 at 17:33 UTC
Last updated Oct 21, 2026.
Overview
Compare with enVVeno Medical Corp, Odyssey Health, Inc. or VIVOS INC, or pick any stock.
- TickerALRTF on OTC1
- IndustrySurgical & Medical Instruments & Apparatus1
- Business address9 Raffles Place, #26-01 Republic Plaza, Singapore, U0 0486194
- Filer categoryNon-accelerated filer4
See how the biggest companies compare on our leaderboards
Company launched the website www.glucurve.ca as part of its future plans to provide a direct to veterinarian clinic sales model in Canada.5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023
Where the money goes
Where each dollar of revenue went, fiscal 2023
- Cost of revenue0¢$22.1K
- Research and development21¢$1.4M
- Selling, general and admin40¢$2.6M
- Interest39¢$2.5M
Out of $25.5K in revenue.3 The company lost money this year.
Financial statements
No quarterly figures reported.
Every line of the income statement as filed: the last 3 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | $25.5K | ||
| Cost of revenue | -$22.1K | ||
| Gross Margin | $3.4K | ||
| Product development costs | $793.3K | $883.9K | $1.4M |
| Professional fees | $617.7K | $512.6K | $814.7K |
| Selling, general and administrative expense | $1.5M | $2.0M | $2.6M |
| Total operating expenses | $2.9M | $3.4M | $4.8M |
| Loss before other items | -$2.9M | -$3.4M | -$4.8M |
| Interest expense | -$19.7M | -$12.4M | -$2.5M |
| Foreign exchange loss | -$246.2K | ||
| Write-off of accounts receivable | -$41.1K | ||
| Write-off of accounts payable | $805.5K | ||
| Loss on settlement of debt | -$139.0K | ||
| Total other items | -$19.2M | -$12.5M | -$2.7M |
| Net Loss | -$22.1M | -$15.9M | -$7.5M |
| Exchange difference on translating foreign operations | -$7.0K | ||
| Comprehensive loss for the year | -$22.1M | -$15.9M | -$7.5M |
| Weighted Average Number of Shares Outstanding, Diluted | 607.0M shares | 598.9M shares | 581.0M shares |
| Earnings Per Share, Diluted | -$0.04 | -$0.03 | -$0.01 |
No quarter-by-quarter statement was filed.
No quarterly figures reported.
Every line of the balance sheet as filed: the last 2 fiscal years (annual) or 2 quarters (quarterly), latest first.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Cash | $20.3K | $40.7K |
| Inventory | $10.8K | $10.9K |
| Prepaid expenses | $16.2K | $28.0K |
| Total assets | $47.4K | $79.5K |
| Accounts payable and accrued liabilities | $1.4M | $2.0M |
| Promissory notes payable to related parties | $3.1M | $4.2M |
| Promissory notes payable | $2.2M | $2.2M |
| Interest payable to related parties | $2.5M | $2.2M |
| Interest payable | $3.7M | $3.5M |
| Lines of credit from related parties | $23.2M | $19.9M |
| Loan payable to related parties | $3.8M | $2.4M |
| Total liabilities | $39.9M | $36.3M |
| Ordinary shares | $31.5M | $31.3M |
| Additional paid-in capital | $86.7M | $68.5M |
| Accumulated other comprehensive loss cumulative translation differences | -$844 | -$844 |
| Accumulated deficit | -$158.0M | -$136.0M |
| Total shareholders deficit | -$39.9M | -$36.2M |
| Total liabilities and shareholders deficit | $47.4K | $79.5K |
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Cash | $20.3K | $40.7K |
| Inventory | $10.8K | $10.9K |
| Prepaid expenses | $16.2K | $28.0K |
| Total assets | $47.4K | $79.5K |
| Accounts payable and accrued liabilities | $1.4M | $2.0M |
| Promissory notes payable to related parties | $3.1M | $4.2M |
| Promissory notes payable | $2.2M | $2.2M |
| Interest payable to related parties | $2.5M | $2.2M |
| Interest payable | $3.7M | $3.5M |
| Lines of credit from related parties | $23.2M | $19.9M |
| Loan payable to related parties | $3.8M | $2.4M |
| Total liabilities | $39.9M | $36.3M |
| Ordinary shares | $31.5M | $31.3M |
| Additional paid-in capital | $86.7M | $68.5M |
| Accumulated other comprehensive loss cumulative translation differences | -$844 | -$844 |
| Accumulated deficit | -$158.0M | -$136.0M |
| Total shareholders deficit | -$39.9M | -$36.2M |
| Total liabilities and shareholders deficit | $47.4K | $79.5K |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net loss | -$22.1M | -$15.9M | -$7.5M |
| Share-based compensation included in product development costs, selling, general and administrative expense, professional fees and interest expense | $18.3M | $11.5M | $2.9M |
| Interest expense on lines of credit | $1.8M | $1.7M | $1.6M |
| Payment of lines of credit interest | -$276.6K | -$257.7K | -$310.6K |
| Accrued interest, borrowing costs and interest accretion on loans payable | $40.0K | $307.8K | $309.7K |
| Non-cash imputed interest expenses | $32.5K | $32.5K | $34.4K |
| Write-off of accounts receivable | $41.1K | ||
| Unrealized foreign exchange | $212.7K | -$74.5K | $35.8K |
| Write-off of accounts payable | -$805.5K | ||
| Loss on settlement of accounts payable | $139.0K | ||
| Increase in accounts receivable | -$41.1K | ||
| Decrease (increase) in inventory | $20 | $137 | -$11.0K |
| Decrease in prepaid expenses | $41.7K | $16.1K | $201.6K |
| Increase in accounts payable and accrued liabilities | $309.5K | $477.7K | $452.4K |
| Increase in interest payable to related parties | $327.2K | $328.2K | $314.1K |
| Increase in interest payable | $203.3K | $203.3K | $217.3K |
| Net cash used in operating activities | -$1.9M | -$1.5M | -$1.6M |
| Proceeds from lines of credit | $1.8M | $427.8K | $794.5K |
| Proceeds from loan payable | $22.4K | ||
| Proceeds from promissory notes | $1.1M | ||
| Proceeds from exercise of warrants | $6.0K | ||
| Proceeds from sales of ordinary shares | $744.7K | ||
| Net cash provided by financing activities | $1.8M | $1.5M | $1.5M |
| Effect of foreign exchange on cash | -$7.0K | ||
| Change in cash | -$20.4K | -$18.4K | -$89.5K |
No quarter-by-quarter statement was filed.
Corporate structure
ALR Technologies SG Ltd. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of ALR Technologies SG Ltd.
- Sidney Chan Filed SC 13D/A on ALR Technologies SG Ltd., latest Nov 18, 2022 (2 filings since Nov 14, 2022)
- ALR Technologies SG Ltd.
Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What ALR Technologies SG Ltd. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Inventory
Leadership
Who has led ALR Technologies SG Ltd., and when. Pick a name to see everywhere that person has worked.
Chief executive
- Chief executive officerSidney Chan Mar 17, 2026 to now9
Board members and other officers (7)
- VP, CorporateYuen Shan Kan Apr 6, 2026 to now10
- Corporate SecretaryBenjamin Szeto Apr 9, 2026 to now11
- Board memberSidney Chan Mar 17, 2026 to now9
- Board memberKenneth Robulak Apr 6, 2026 to now12
- Board memberYuen Shan Kan Apr 6, 2026 to now10
- Board memberPeter H. Stafford Apr 9, 2026 to now13
- Board memberRonald Cheng May 15, 2026 to now14
Former names
- ALR Technologies SG Pte. Ltd.May 24, 2022 to Sep 23, 20224
Timeline
- Mar 17, 2026New chief executive Sidney Chan becomes CEO9
Filings
50 filings to the SEC since October 2021: 6 annual reports, 6 insider forms, 2 large holders, 36 other. The latest 20:
- Jun 30, 20266-K EDGAR
- May 20, 20266-K EDGAR
- May 15, 20263 EDGAR
- Apr 30, 202620-F EDGAR
- Apr 9, 20263 EDGAR
- Apr 9, 20263 EDGAR
- Apr 6, 20263 EDGAR
- Apr 6, 20263 EDGAR
- Mar 17, 20263 EDGAR
- Jan 5, 20266-K EDGAR
- Dec 30, 20256-K EDGAR
- Dec 30, 20256-K EDGAR
- Jul 7, 20256-K EDGAR
- Jun 26, 20256-K EDGAR
- May 2, 202520-F/A EDGAR
- May 1, 2025NT 20-F EDGAR
- May 1, 202520-F EDGAR
- Dec 30, 20246-K EDGAR
- Jul 8, 2024UPLOAD EDGAR
- Jul 1, 202420-F/A EDGAR
The 50 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Sidney ChanSC 13D/A, 2 filings Nov 14, 2022 to Nov 18, 202215
SEC filer profile
How ALR Technologies SG Ltd. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARALR Technologies SG Ltd.1
- CIK0001930419
- Filer statusNon-accelerated filer not an emerging growth company; a shell company5
- Incorporated inU05
- Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address9 Raffles Place, #26-01 Republic Plaza, Singapore, U0 0486191
- Phone65312929241
- Shares outstanding645,466,844 shares as of Dec 31, 20255
- AuditorDMCL LLP, Vancouver, Canada PCAOB ID 1173; no auditor attestation of internal control over financial reporting5
- On EDGAR sinceMay 24, 20221
- Filings50 in all: 6-K (14), 3 (6), CORRESP (5), 20-F (4), F-4/A (4), UPLOAD (4), 20-F/A (2), 425 (2)1
All 16 form types
SEC STAFF LETTER (2), 424B3 (1), 8-K12G3 (1), EFFECT (1), F-4 (1), NT 20-F (1), SC 13D (1), SC 13D/A (1)
- Latest filingsAnnual report (20-F) Apr 30, 2026
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2Yahoo FinanceALRTF quote
- 3
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARSidney Chan, Chief executive officer
- 10SEC EDGARYuen Shan Kan, VP, Corporate
- 11SEC EDGARBenjamin Szeto, Corporate Secretary
- 12SEC EDGARKenneth Robulak, Board member
- 13SEC EDGARPeter H. Stafford, Board member
- 14SEC EDGARRonald Cheng, Board member
- 15